Drug Shortage Report for SANDOZ GLICLAZIDE MR

Last updated on 2024-12-07 History
Report ID 226677
Drug Identification Number 02461331
Brand name SANDOZ GLICLAZIDE MR
Common or Proper name GLICLAZIDE MR
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 60MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60MRT
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-04-30
Estimated end date
Actual end date 2024-12-06
Shortage status Resolved
Updated date 2024-12-07
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-12-07 English Compare
v6 2024-12-06 French Compare
v5 2024-12-06 English Compare
v4 2024-05-01 English Compare
v3 2024-04-30 French Compare
v2 2024-04-30 English Compare
v1 2024-04-30 English Compare

Showing 1 to 7 of 7